Furthermore, strong and broad CTA- & SALL4-specific, but not AFP-specific, T cell responses were observed in patients with HCC that was early-stage, less aggressive or with a low relapse rate at the 1-year follow-up. Here, AFP is linked to hepatocellular carcinoma.